MSOS ETF Analysis And what to watch for MSOS ETF

Sandoz partners with Samsung Bioepis to license Stelara biosimilar – Pharmaceutical Technology

Stelara is a high-grossing drug for J&J, generating $3.2bn in sales in H1 2023. Image Credit: OleksSH / Shutterstock. Sandoz has partnered with Samsung Bioepis

September 11, 2023

Congress likely to kick the can on covid-era telehealth policies

Nearly two hours into a Capitol Hill hearing focused on rural health, Rep. Brad Wenstrup emphatically told the committee’s five witnesses: “Hang with us.”

April 10, 2024

CMS Finalizes New Interoperability and Prior Authorization Rule

What You Should Know: The Biden-Harris Administration has finalized a new rule that streamlines the prior authorization process and improves health data exchange across the

January 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.